NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









NoNO Inc.

NoNO Inc.

Private
Toronto, OntarioHealthcare & Life Scienceshttps://www.nonoinc.ca/

Last Round

Grant

Nov 1, 2021

Total Funding Raised

$10.3M

Company Overview

NoNO Inc. is a biotechnology company that develops therapeutic drugs for areas of unmet medical needs, with a focus on diseases of the nervous system like stroke, traumatic brain injury, and neuropathic pain.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Medical Devices

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

nerinetidePSD-95 inhibitorneuroprotectionacute ischemic strokestroke treatmentclinical stage biotechpeptide therapeuticbiopharmadrug discoverypharmaceutical licensingneurological disordersCNS therapeuticsautoinjectorStrokePenStroke EpiPentraumatic brain injuryTBIsubarachnoid hemorrhageSAH

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NoNO Inc. Comparables

Compare NoNO Inc. with similar companies based on industry and business-model similarity.

NoNO Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

NoNO Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 1, 2021
GrantDec 20, 2020
Series AMay 24, 2013

Key People

Founding team and executive leadership

Michael Tymianski

President And CEO, President And CEO

Executive Team

NoNO Inc. Investors

Notable investors and investment history

NoNO Inc. investors
InvestorRounds
Blue Sky CapitalSeries A
Mizuho Asia PartnersSeries A
National Research Council of CanadaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 24, 2025

    Monthly visitors grew 93% MoM, from 725 to 1.4K.

  • Nov 25, 2024

    Grew 23% QoQ, from 80 to 98 employees.

NoNO Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NoNO Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NoNO Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto, Ontario
Employee Range93
Year Founded2003
Last FundingNov 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.